Revolution Medicines, Inc. (RVMD) is a clinical-stage precision oncology company that develops novel targeted therapies for patients with RAS-addicted cancers, which represent approximately 30% of human cancers; its research and development…
HQ: Redwood City, CA, United States of Americawww.revmed.com
USD203.77+0.21%vs prev. close
Market snapshot
Price
USD203.77
Daily move
+0.21%
P/E
—
EPS TTM
-8.88
Dividend yield
—
Beta
1.41
Market cap
43.7B
Price history
RVMD price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Revolution Medicines
RVMD
Biotechnology
43.7
—
—
-3.0%
-0.7%
+32.4%
+114.8%
+340.7%
+155.8%
🔒
Subscribe to Equity Analytics to compare RVMD with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.